S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Roku stock and the mother of all entry opportunities
The perfect AI stock under $10 (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
The perfect AI stock under $10 (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Roku stock and the mother of all entry opportunities
The perfect AI stock under $10 (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
The perfect AI stock under $10 (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Roku stock and the mother of all entry opportunities
The perfect AI stock under $10 (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
The perfect AI stock under $10 (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Roku stock and the mother of all entry opportunities
The perfect AI stock under $10 (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
The perfect AI stock under $10 (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard

Genmab A/S (GMAB) Short Interest Ratio & Short Volume

$29.11
+0.16 (+0.55%)
(As of 02/22/2024 ET)

Genmab A/S Short Interest Data

Current Short Volume
2,050,000 shares
Previous Short Volume
1,870,000 shares
Change Vs. Previous Month
+9.63%
Dollar Volume Sold Short
$56.60 million
Short Interest Ratio / Days to Cover
3.1
Last Record Date
January 31, 2024
Outstanding Shares
660,740,000 shares
Float Size
653,220,000 shares
Short Percent of Float
0.31%
Today's Trading Volume
450,479 shares
Average Trading Volume
670,344 shares
Today's Volume Vs. Average
67%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Genmab A/S ?

Sign up to receive the latest short interest report for Genmab A/S and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GMAB Short Interest Over Time

GMAB Days to Cover Over Time

GMAB Percentage of Float Shorted Over Time

Genmab A/S Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/20242,050,000 shares $56.60 million +9.6%0.3%3.1 $27.61
1/15/20241,870,000 shares $59.11 million +7.5%N/A2.4 $31.61
12/31/20231,740,000 shares $55.40 million +8.8%N/A2.1 $31.84
12/15/20231,600,000 shares $49.38 million +8.1%N/A1.9 $30.86
11/30/20231,480,000 shares $46.78 million -3.3%N/A1.8 $31.61
11/15/20231,530,000 shares $48.52 million -15.9%N/A1.9 $31.71
10/31/20231,820,000 shares $51.69 million -22.6%0.3%2.6 $28.40
10/15/20232,350,000 shares $75.86 million -10.0%N/A3.6 $32.28
9/30/20232,610,000 shares $92.05 million -2.6%N/A5.3 $35.27
9/15/20232,680,000 shares $101.79 million -7.3%N/A5.4 $37.98
8/31/20232,890,000 shares $110.66 million -16.2%N/A6 $38.29
8/15/20233,450,000 shares $128.31 million -17.7%N/A7.3 $37.19
7/31/20234,190,000 shares $173.30 million +7.4%N/A8.7 $41.36
7/15/20233,900,000 shares $156.08 million +1.8%N/A8.9 $40.02
6/30/20233,830,000 shares $145.58 million +13.3%N/A9.5 $38.01
6/15/20233,380,000 shares $130.98 million -6.4%N/A8.8 $38.75
5/31/20233,610,000 shares $141.55 million +6.8%N/A8.9 $39.21
5/15/20233,380,000 shares $142.43 million -4.5%N/A7.2 $42.14
4/30/20233,540,000 shares $145.18 million +1.7%N/A7.6 $41.01
4/15/20233,480,000 shares $144.70 million +0.3%N/A7 $41.58
3/31/20233,470,000 shares $131.03 million +12.3%N/A6.7 $37.76
3/15/20233,090,000 shares $110.34 million +7.3%N/A5.6 $35.71
2/28/20232,880,000 shares $108.17 million -4.6%N/A4.6 $37.56
2/15/20233,020,000 shares $119.95 million +1.3%N/A4.9 $39.72
1/31/20232,980,000 shares $116.67 million -4.8%0.5%4.6 $39.15
1/15/20233,130,000 shares $125.70 million -4.9%N/A4.6 $40.16
12/30/20223,290,000 shares $139.43 million +2.5%N/A5 $42.38
12/15/20223,210,000 shares $143.68 million -13.7%N/A4.6 $44.76
11/30/20223,720,000 shares $173.09 million +8.1%N/A6.1 $46.53
11/15/20223,440,000 shares $148.26 million +0.3%N/A5.9 $43.10
10/31/20223,430,000 shares $132.09 million -5.0%N/A6 $38.51
10/15/20223,610,000 shares $131.77 million +0.8%N/A6 $36.50
9/30/20223,580,000 shares $115.03 million +12.6%N/A5.9 $32.13
9/15/20223,180,000 shares $115.82 million +8.5%N/A5.5 $36.42
8/31/20222,930,000 shares $103.99 million -19.7%N/A4.9 $35.49
8/15/20223,650,000 shares $135.93 million +37.2%N/A5.8 $37.24
7/31/20222,660,000 shares $94.75 million +15.7%N/A3.8 $35.62
7/15/20222,300,000 shares $78.91 million +1.8%N/A3.4 $34.31
6/30/20222,260,000 shares $73.43 million -8.9%N/A3.3 $32.49
6/15/20222,480,000 shares $68.65 million +3.8%N/A3.7 $27.68
Critical asset just had biggest fall on record (Ad)

What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."

Full details and steps to take here.













GMAB Short Interest - Frequently Asked Questions

What is Genmab A/S's current short interest?

Short interest is the volume of Genmab A/S shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 2,050,000 shares of GMAB short. 0.31% of Genmab A/S's shares are currently sold short. Learn More on Genmab A/S's current short interest.

What is a good short interest ratio for Genmab A/S?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GMAB shares currently have a short interest ratio of 3.0. Learn More on Genmab A/S's short interest ratio.

Which institutional investors are shorting Genmab A/S?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Genmab A/S: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Genmab A/S?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.31% of Genmab A/S's floating shares are currently sold short.

Is Genmab A/S's short interest increasing or decreasing?

Genmab A/S saw a increase in short interest in January. As of January 31st, there was short interest totaling 2,050,000 shares, an increase of 9.6% from the previous total of 1,870,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Genmab A/S's float size?

Genmab A/S currently has issued a total of 660,740,000 shares. Some of Genmab A/S's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Genmab A/S currently has a public float of 653,220,000 shares.

How does Genmab A/S's short interest compare to its competitors?

0.31% of Genmab A/S's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Genmab A/S: Alnylam Pharmaceuticals, Inc. (3.18%), BioMarin Pharmaceutical Inc. (1.68%), Viatris Inc. (2.86%), Teva Pharmaceutical Industries Limited (1.63%), Sarepta Therapeutics, Inc. (5.53%), Dr. Reddy's Laboratories Limited (0.46%), Karuna Therapeutics, Inc. (4.48%), Legend Biotech Co. (5.53%), United Therapeutics Co. (2.21%), Roivant Sciences Ltd. (5.37%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Genmab A/S stock?

Short selling GMAB is an investing strategy that aims to generate trading profit from Genmab A/S as its price is falling. GMAB shares are trading up $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Genmab A/S?

A short squeeze for Genmab A/S occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GMAB, which in turn drives the price of the stock up even further.

How often is Genmab A/S's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GMAB, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:GMAB) was last updated on 2/23/2024 by MarketBeat.com Staff

From Our Partners